IKONICS Reports 2016 Results

Print
| Source: IKONICS Corporation

DULUTH, Minn., Feb. 27, 2017 (GLOBE NEWSWIRE) -- IKONICS Corporation (NASDAQ:IKNX), a Duluth-based imaging technology company announced 2016 financial results.

IKONICS CEO Bill Ulland said: “This has been a year of contrasts for IKONICS.  Sales of Advanced Material Solutions (AMS), our aerospace business, grew 66% over 2015. Most of these sales were to one customer, and we expect that this business will continue for future years.  AMS has achieved industry recognition for service and quality. We are anticipating additional business from three potential new customers in 2017 and 2018. 

“IKONICS Imaging also had a good year, with sales up 8% over 2015, driven primarily by a new customer, which is continuing to increase its orders. We expect to introduce a new, patent-applied-for product to this market this year, which we believe will be an important contributor to sales and profits.”

Ulland noted that DTX, IKONICS’ automotive-based product line, experienced a 15% decline in sales, mirroring the segment of the automotive market the company serves. But based on firm orders in house, he expects that decline to reverse in the first half of 2017 and generate good sales and profits.

“Our traditional domestic screen print supply business was down 3%, reflecting the mature nature of this market. To counteract this, we are making a major effort in the growing printed electronics sector where we are developing a unique product that allows the printing of very fine circuits for touch pads, wearable electronics, antennas and other applications.  This is a large market that could bring us significant profits,” he said.

Ulland continued: “Our international business was down 8%, reflecting the strong dollar and a weak world economy.  We are looking for the printed electronics market described above and the new product being developed for IKONICS Imaging to improve our export business.”

“For the year, overall sales were flat with 2015, with AMS and IKONICS Imaging countering the decline in International and DTX,” Ulland said. “Unfortunately, we were hit with a large unforeseen increase in health care expenses in the fourth quarter of 2016. For the year, our employee health care costs were $721,000 compared to $408,000 in 2015.  This resulted in a loss of $0.03 per diluted share for the year compared to 2015 earnings of $0.07 per diluted share.  Without the $313,000 increase in healthcare costs, pre-tax earnings on a non-GAAP basis1 would have increased by 8% over 2015.  

1 Reconciliation to GAAP figure below.

This press release contains forward-looking statements regarding sales, gross profits, net earnings, balance sheet position, new products, new business initiatives and facilities expansion that involve risks and uncertainties. The Company's actual results could differ materially as a result of domestic and global economic conditions, downturns in the aerospace or automotive industries, unexpected production delays by customers using the Company’s products, competitive market conditions, changes in consumer preferences, inability to commercialize technologies the Company is developing on the anticipated timeline or at all, acceptance of new products the Company offers, introduction of new products or technologies by competitors, unexpected capital expenditure requirements, delays in completing planned expansions, the ability to control operating costs without impacting growth as well as the factors described in the Company's Forms 10-K, and 10-Q, and other reports on file with the SEC.

 
IKONICS Corporation
CONDENSED STATEMENTS OF OPERATIONS
For the Three and Twelve Months Ended December 31, 2016 and 2015
              
    Three Months Ended  Twelve Months Ended
    12/31/16  12/31/15  12/31/16  12/31/15
Net Sales  $4,752,612  $4,767,899 $17,569,901  $17,562,066
              
Cost of goods sold   3,002,061   2,981,392  11,332,991   11,417,474
              
Gross profit   1,750,551   1,786,507  6,236,910   6,144,592
              
Operating Expenses   1,661,858   1,478,993  6,258,914   5,923,774
              
Earnings (loss) from operations   88,693   307,514  (22,004)  220,818
              
Interest Expense   (21,502)    (58,222)  
              
Other   4,484   158  11,165   4,189
              
Income (loss) before income taxes   71,675   307,672  (69,061)  225,007
              
Income tax expense (benefit)   65,415   88,198  (4,000)  90,000
              
Net income (loss)  $6,260  $219,474 $(65,061) $135,007
              
Earnings (loss) per common share-basic and diluted  $0.00  $0.11 $(0.03) $0.07
              
Average diluted shares outstanding   2,018,831   2,018,490  2,018,649   2,018,591
              

  

Condensed Balance Sheets
As of December 31, 2016 and December 31, 2015
         
    12/31/2016   12/31/2015
Assets        
Current assets  $9,045,472  $6,721,891
Property, plant, and equipment, net   8,912,395   7,957,330
Intangible assets, net   338,127   336,096
   $18,295,994  $15,015,317
Liabilities and Stockholders' Equity        
Current liabilities  $1,313,377  $1,135,102
Deferred income taxes   446,000   385,000
Long-term debt   3,077,457   
Stockholders' equity   13,459,160   13,495,215
   $18,295,994  $15,015,317
         

 

CONDENSED STATEMENTS OF CASH FLOWS
For the Twelve Months Ended December 31, 2016 and 2015
         
    12/31/2016   12/31/2015
Net cash provided by operating activities  $916,947   $1,466,061 
Net cash used in investing activities   (5,316,572)   (1,153,809)
Net cash provided by financing activities   3,199,872     
         
Net increase (decrease) in cash and cash equivalents   (1,199,753)   312,252 
Cash and cash equivalents at beginning of period   2,248,466    1,936,214 
         
Cash and cash equivalents at end of period  $1,048,713   $2,248,466 
         

RECONCILIATION OF GAAP TO NON-GAAP PRE-TAX EARNINGS

We report our financial results in accordance with U.S. generally accepted accounting principles (“GAAP”). We have provided non-GAAP pre-tax earnings to assist investors in comparing earnings on a year-over-year basis and because management believes it is a useful metric in evaluating ongoing performance of our company. Reconciliation to the comparable GAAP measure is below.

        
    Twelve Months Ended
    12/31/16  12/31/15
GAAP pre-tax earnings (loss)  $(69,061) $225,007
Percentage decrease from prior fiscal year   (131%)  
        
Add: Increase in health care costs   313,000  
        
Non-GAAP pre-tax earnings  $243,939 $225,007
Percentage increase from prior fiscal year   8%  
        

 

News Contact:
Bill Ulland
Chairman, President & CEO
(218) 628-2217